Publications by authors named "Mark Balk"

Claim this Profile
N
Number needed to treat and associated cost analysis of zanubrutinib vs ibrutinib in chronic lymphocytic leukemia.
Asher Chanan-Khan, Kirollos Hanna, Mei Xue, Marjan Massoudi, Mark Balk

J Manag Care Spec Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US.
Jason C Allaire, Mark Balk, Soraya Azmi, Heather L Handl, Keri Yang

Curr Med Res Opin· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed evolution and biophysical characterization of a full-length, soluble, human caveolin-1 variant.
Joshua N Smith, Joshua M Edgar, J Mark Balk, Mariam Iftikhar, Jessica C Fong

Biochim Biophys Acta Proteins Proteom· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial.
Nancy Devlin, Michael Herdman, Marco Pavesi, De Phung, Shevani Naidoo, Mark Balk

Health Qual Life Outcomes· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.
Marjan Massoudi, Mark Balk, Hongbo Yang, Cat N Bui, Bhavik J Pandya

J Med Econ· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity-Guided Design of Caveolin-1 Ligands for Deoligomerization.
Amanda J H Gilliam, Joshua N Smith, Dylan Flather, Kevin M Johnston, Andrew M Gansmiller, Mark Balk

J Med Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
Cat N Bui, Ken O'Day, Scott Flanders, Nina Oestreicher, Peter Francis, Mark Balk

J Manag Care Spec Pharm· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen Receptor Folding Modulates cSrc Kinase SH2 Interaction via a Helical Binding Mode.
Lidia Nieto, Inga M Tharun, Mark Balk, Hans Wienk, Rolf Boelens

ACS Chem Biol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype-specific modulation of estrogen receptor-coactivator interaction by phosphorylation.
Inga M Tharun, Lidia Nieto, Christian Haase, Marcel Scheepstra, Mark Balk

ACS Chem Biol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis